Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 3638-3641, August 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, D.
Right arrow Articles by Wei, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, D.
Right arrow Articles by Wei, Q.

In Vitro Induction of Benzo(a)pyrene Diol Epoxide-DNA Adducts in Peripheral Lymphocytes as a Susceptibility Marker for Human Lung Cancer1

Donghui Li2, Mianying Wang, Lie Cheng, Margaret R. Spitz, Walter N. Hittelman and Qingyi Wei2

Departments of Clinical Investigations [D. L., M. W., W. N. H.] and Epidemiology [L. C., M. R. S., Q. W.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Given the same exposure, DNA adduct profiles can be considered as a phenotypic marker for carcinogen metabolism and DNA repair, which may reflect individual susceptibility to chemical carcinogenesis. Based on this notion, we have established a straightforward assay that measures induced DNA adducts in peripheral lymphocytes exposed in vitro to a model carcinogen, benzo(a)pyrene diol epoxide (BPDE) by 32P-postlabeling. To test the hypothesis that the levels of induced DNA adducts are a predictor for cancer risk, we conducted a pilot study of 21 lung cancer patients and 41 healthy frequency-matched controls. We found that the peripheral lymphocytes of cancer patients tended to accumulate higher levels of BPDE-DNA adducts than controls did (mean ± SE of relative adduct labeling x 107 value; 59.6 ± 12.0 versus 39.4 ± 6.1 for cases and controls, respectively; P = 0.09). Using the tertile relative adduct labeling value of controls (10 adducts/107 nucleotides) as the cutoff point, 18 of 21 cases and 23 of 41 controls distributed above this level (odds ratio, 4.7; 95% confidence interval, 1.2–18.5). In logistic regression analysis, the level of induced adduct was an independent risk factor (odds ratio, 6.4; 95% confidence interval, 1.3–29.4) after adjustment for the potential confounding factors, i.e., age, sex, ethnicity, and smoking. Stratified analyses showed that greater differences in DNA adduct levels induced by BPDE between cases and controls were observed in individuals younger than 65 years and in nonsmokers. Despite the small sample size, the significant association between the level of BPDE-induced DNA adducts and risk for lung cancer suggests that this assay is a promising method for further investigations.

1 This investigation was supported in part by an institutional start-up fund grant (to Q.W.) and in part by NIH Grants CA 55769 (to M. R. S.) and CA 68437 (to W. N. H.).

2 To whom requests for reprints may be addressed, at Departments of Clinical Investigation (D. L., Box 19) and Epidemiology (Q. W., Box 189), The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 5/31/96. Accepted 7/ 3/96.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
H. Zhao, L.-E Wang, D. Li, R. M. Chamberlain, E. M. Sturgis, and Q. Wei
Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis
Carcinogenesis, August 1, 2008; 29(8): 1560 - 1566.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei
Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck
Cancer Res., June 1, 2008; 68(11): 4479 - 4485.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz
A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma
Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Pavanello, A. Pulliero, E. Siwinska, D. Mielzynska, and E. Clonfero
Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers
Carcinogenesis, January 1, 2005; 26(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Ito, K. Matsuo, N. Hamajima, T. Mitsudomi, T. Sugiura, T. Saito, T. Yasue, K.-M. Lee, D. Kang, K.-Y. Yoo, et al.
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk
Carcinogenesis, August 1, 2004; 25(8): 1395 - 1401.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. Benhamou, A. Laplanche, B. Guillonneau, A. Mejean, F. Desgrandchamps, C. Schrameck, V. Degieux, and F. Perin
DNA adducts in normal bladder tissue and bladder cancer risk
Mutagenesis, September 1, 2003; 18(5): 445 - 448.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. Garry, F. Nesslany, E. M. Aliouat, J.-M. Haguenoer, and D. Marzin
Potent genotoxic activity of benzo[a]pyrene coated onto hematite measured by unscheduled DNA synthesis in vivo in the rat
Mutagenesis, September 1, 2003; 18(5): 449 - 455.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Airoldi, F. Orsi, C. Magagnotti, R. Coda, D. Randone, G. Casetta, M. Peluso, A. Hautefeuille, C. Malaveille, and P. Vineis
Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies
Carcinogenesis, May 1, 2002; 23(5): 861 - 866.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Moorthy, K. P. Miller, W. Jiang, and K. S. Ramos
The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: role of cytochrome P4501B1
Cardiovasc Res, March 1, 2002; 53(4): 1002 - 1009.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Butkiewicz, M. Rusin, L. Enewold, P. G. Shields, M. Chorazy, and C. C. Harris
Genetic polymorphisms in DNA repair genes and risk of lung cancer
Carcinogenesis, April 1, 2001; 22(4): 593 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Li, P. F. Firozi, L.-E Wang, C. H. Bosken, M. R. Spitz, W. K. Hong, and Q. Wei
Sensitivity to DNA Damage Induced by Benzo(a)pyrene Diol Epoxide and Risk of Lung Cancer: A Case-Control Analysis
Cancer Res., February 1, 2001; 61(4): 1445 - 1450.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz
Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study
J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. K. Wiencke, S. W. Thurston, K. T. Kelsey, A. Varkonyi, J. C. Wain, E. J. Mark, and D. C. Christiani
Early Age at Smoking Initiation and Tobacco Carcinogen DNA Damage in the Lung
J Natl Cancer Inst, April 7, 1999; 91(7): 614 - 619.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F. P. Perera
Environment and Cancer: Who Are Susceptible?
Science, November 7, 1997; 278(5340): 1068 - 1073.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.